Files
Download
Download Full Text (262 KB)
Description
Proteasome inhibitors are drugs used to treat multiple myeloma. Currently, three are approved by the FDA.
Publisher Location
Las Vegas (Nev.)
Publication Date
12-9-2022
Publisher
University of Nevada, Las Vegas
Language
English
Controlled Subject
Multiple myeloma;Myeloma proteins;
Disciplines
Food and Drug Law
File Format
File Size
204 KB
Recommended Citation
Chi, Ethan, "Retroviral Protease (RVP) DDI2 is a Viable Alternative for Full-Length (FL) DDI2" (2022). Undergraduate Research Symposium Lightning Talks. 21.
https://digitalscholarship.unlv.edu/durep_lightning/21
Rights
IN COPYRIGHT. For more information about this rights statement, please visit http://rightsstatements.org/vocab/InC/1.0/
Comments
Faculty Mentor: Gary Kleiger